phenylethyl alcohol has been researched along with Carcinoma, Squamous Cell of Head and Neck in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SD; Shin, JA; Yu, HJ | 1 |
| Kagaya, H; Okudaira, N; Sakagami, H; Sugita, Y; Takao, K; Toda, K; Uesawa, Y | 1 |
| Chang, KS; Chen, YJ; Chiang, KC; Chuang, ST; Chung, LC; Feng, TH; Juang, HH; Lee, JC; Tsui, KH | 1 |
3 other study(ies) available for phenylethyl alcohol and Carcinoma, Squamous Cell of Head and Neck
| Article | Year |
|---|---|
Inhibition of focal adhesion kinase/paxillin axis by caffeic acid phenethyl ester restrains aggressive behaviors of head and neck squamous cell carcinoma in vitro.
Topics: Cadherins; Caffeic Acids; Cell Line, Tumor; Cell Movement; Focal Adhesion Protein-Tyrosine Kinases; Head and Neck Neoplasms; Humans; Paxillin; Phenylethyl Alcohol; Squamous Cell Carcinoma of Head and Neck | 2023 |
Quantitative Structure-Cytotoxicity Relationship of Cinnamic Acid Phenetyl Esters.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Child; Cinnamates; Esters; Fibroblasts; Head and Neck Neoplasms; Humans; Male; Mouth Neoplasms; Phenylethyl Alcohol; Quantitative Structure-Activity Relationship; Squamous Cell Carcinoma of Head and Neck | 2018 |
Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
Topics: Animals; Caffeic Acids; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Intracellular Signaling Peptides and Proteins; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Phenylethyl Alcohol; Promoter Regions, Genetic; Squamous Cell Carcinoma of Head and Neck; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |